Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Candel Therapeutics, Inc. - Common Stock
(NQ:
CADL
)
8.750
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
21,138
Open
8.750
Bid (Size)
8.770 (3)
Ask (Size)
8.960 (40)
Prev. Close
8.750
Today's Range
8.750 - 8.750
52wk Range
1.100 - 14.60
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why FedEx Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
December 20, 2024
Via
Benzinga
Candel Therapeutics Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
December 16, 2024
From
Candel Therapeutics
Via
GlobeNewswire
Performance
YTD
+503.45%
+503.45%
1 Month
+73.61%
+73.61%
3 Month
+26.08%
+26.08%
6 Month
+42.28%
+42.28%
1 Year
+667.54%
+667.54%
More News
Read More
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 13, 2024
Via
Benzinga
What's Going On With Candel Therapeutics Shares Friday?
December 13, 2024
Via
Benzinga
Candel Therapeutics, 8x8 And Other Big Stocks Moving Lower In Friday's Pre-Market Session
December 13, 2024
Via
Benzinga
Why RH Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
December 13, 2024
Via
Benzinga
Candel Therapeutics Announces Pricing of Public Offering
December 12, 2024
From
Candel Therapeutics
Via
GlobeNewswire
Candel Therapeutics Announces $80 Million Proposed Public Offering
December 12, 2024
From
Candel Therapeutics
Via
GlobeNewswire
Candel Therapeutics Shares Are Up Today: What's Going On?
December 12, 2024
Via
Benzinga
Gamestop, Adobe, Meta, Candel Therapeutics, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
December 11, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 11, 2024
Via
Benzinga
Crude Oil Jumps 2%; Macy's Lowers Earnings Forecast
December 11, 2024
Via
Benzinga
Exposures
Fossil Fuels
10 Health Care Stocks Whale Activity In Today's Session
December 11, 2024
Via
Benzinga
Nasdaq Surges Over 1%; US Inflation Rises In-Line With Expectations
December 11, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Candel Therapeutics Stock Surges Over 100% - Here's Why
December 11, 2024
Via
Benzinga
Candel Skyrockets By Triple Digits On A Potential First-In-20-Years Cancer Drug
December 11, 2024
Via
Investor's Business Daily
Candel Therapeutics Announces CAN-2409 Achieved Primary Endpoint in Phase 3 Prostate Cancer Trial, Showing Significantly Improved Disease-Free Survival
December 11, 2024
From
Candel Therapeutics
Via
GlobeNewswire
Candel Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights
November 14, 2024
From
Candel Therapeutics
Via
GlobeNewswire
Candel Therapeutics to Present at Jefferies London Healthcare Conference 2024
November 07, 2024
From
Candel Therapeutics
Via
GlobeNewswire
Candel Therapeutics to Present Preclinical Data at SITC Annual Meeting Showing Promise for CAN-3110 in Melanoma, Signaling Potential Indication Expansion Beyond Recurrent High-Grade Glioma
November 05, 2024
From
Candel Therapeutics
Via
GlobeNewswire
Candel Therapeutics Showcases Innovative Cancer Therapy Candidates at 16th Annual International Oncolytic Virotherapy Conference (IOVC)
October 28, 2024
From
Candel Therapeutics
Via
GlobeNewswire
Candel Therapeutics to Present Preclinical Data on Therapeutic Potential of CAN-3110 in Melanoma at SITC 2024 Annual Meeting
October 04, 2024
From
Candel Therapeutics
Via
GlobeNewswire
Candel Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
September 03, 2024
From
Candel Therapeutics
Via
GlobeNewswire
CADL Stock Earnings: Candel Therapeutics Reported Results for Q2 2024
August 13, 2024
Via
InvestorPlace
Candel Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Highlights
August 13, 2024
From
Candel Therapeutics
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.